Rossmax International

Rossmax International EBIT per Share

The EBIT per Share of Rossmax International (4121.TWO) as of Nov 1, 2026 is -0.90 TWD. In the previous year, EBIT per Share was -0.96 TWD — a change of -5.68% (higher).

EBIT per Share

-0.90TWD

YoY

-5.68%

Last updated:

EBIT per Share of Rossmax International is 2025 -0.90 TWD. EBIT per Share of Rossmax International was 2024 -0.96 TWD. It decreases by -5.68% higher compared to the previous year.

The Rossmax International EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
0.38 TWD
Jan 1, 2019
0.74 TWD
Jan 1, 2020
2.53 TWD
Jan 1, 2021
2.15 TWD
Jan 1, 2022
3.51 TWD
Jan 1, 2023
0.46 TWD
Jan 1, 2024
-0.96 TWD
Jan 1, 2025
-0.90 TWD
The Rossmax International EBIT per Share history
YEAREBIT per ShareYoY
-0.90TWD-5.68%
-0.96TWD-308.18%
0.46TWD-86.91%
3.51TWD+62.96%
2.15TWD-15.05%
2.53TWD+243.62%
0.74TWD+92.59%
0.38TWD-35.03%
0.59TWD-135.71%
-1.65TWD-3.87%
-1.72TWD+28.86%
-1.33TWD+36.52%
-0.98TWD-1,051.81%
0.10TWD-77.23%
0.45TWD-70.88%
1.55TWD+108.79%
0.74TWD-331.68%
-0.32TWD-116.05%
1.99TWD+109.67%
0.95TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rossmax International Stock analysis

What does Rossmax International do? Rossmax International Ltd, listed on the Taiwan Stock Exchange under ticker 4121.TWO with ISIN TW0004121009, is a healthcare company headquartered in Taipei City, Taiwan. Founded through an IPO on November 28, 2002, the company employs 965 people. It operates within the healthcare sector, focusing on the design, manufacture, research, and development of healthcare products. Its primary product lines include digital sphygmomanometers, respiratory therapy products, temperature series products, and blood oxygen meters. Rossmax distributes its products both domestically within Taiwan and internationally across markets in Europe, the Americas, and other regions. The company maintains a website at https://www.rossmax.com/ for further information. Rossmax International Ltd does not disclose specific financial figures or additional details beyond its operational scope and product offerings as provided in the source material. The company's activities are centered around healthcare innovation and product development aimed at meeting consumer health needs through technological solutions. Rossmax International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rossmax International stock

EBIT per Share of Rossmax International is -0.90 TWD in 2025.

EBIT per Share of Rossmax International changed from -0.96 TWD to -0.90 TWD, representing a -5.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Rossmax International since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Rossmax International

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Rossmax International